Jinxin Fertility Group Limited provided financial guidance for the year ended December 31, 2019. The company expected that the net profit of the Group for the year ended December 31, 2019 will increase by over 90% compared to that of the Group for the year ended December 31, 2018. Such increase was primarily attributable to (i) the acquisition of the United States operations by the Group in December 2018; and (ii) the increase in IVF (in vitro fertilization) treatment cycles and profit margin of the Group.